Silence Therapeutics Plc - ADR - SLN - stock price prediction, stock price target, analyst ratings from 7 analysts

Silence Therapeutics Plc - ADR has a share price target of US$ 34, revenue growth forecast of -54.8%, and profit growth estimate of -125.7% for FY25, based on top 7 analyst calls.